- Federal Judge Restricts ‘Continuous’ Employment Harassment Claims to 300-Day Window
- Federal Judge Restricts ‘Continuous’ Employment Harassment Claims to 300-Day Window
- Extend Lockstep or Dive Into Nonequity Partnership? Freshfields Is Grappling with an ‘Ideological Dilemma’
- Extend Lockstep or Dive Into Nonequity Partnership? Freshfields Is Grappling with an ‘Ideological Dilemma’
- How I Made Practice Group Chair: ‘Be Engaged and Proactive in Your Career and at Your Firm,’ Says Amanda Zablocki of Sheppard Mullin
- How I Made Practice Group Chair: ‘Be Engaged and Proactive in Your Career and at Your Firm,’ Says Amanda Zablocki of Shepperd Mullin
- How I Made Practice Group Chair: ‘Be Engaged and Proactive in Your Career and at Your Firm,’ Says Amanda Zablocki of Sheppard Mullin
- ‘Just Ship It’: How to Prevent Heat-of-the-Moment Emails From Capsizing Your Company
- ‘Just Ship It’: How to Prevent Heat-of-the-Moment Emails From Capsizing Your Company
- When are TROs Appealable? Trump Admin Cases Put Question in Spotlight
- When are TROs Appealable? Trump Admin Cases Put Question in Spotlight
- ‘Everyone, Stop Talking!’: Judge Sends Fight Between Kline & Specter and Ex-Associate to Arbitration
- ‘Everyone, Stop Talking!’: Judge Sends Fight Between Kline & Specter and Ex-Associate to Arbitration
- Read the Verdict: Federal Jury Finds Amgen Liable in Drug Monopolization Case
- Read the Verdict: Federal Jury Finds Amgen Liable in Drug Monopolization Case